N01-AI-25465/AI/NIAID NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2003	1
2004	5
2005	2
2006	4
2007	3
2008	2
2009	5
2010	3
2024	0

1

Huang DB, Chappell C, Okhuysen PC. Huang DB, et al. Semin Pediatr Infect Dis. 2004 Oct;15(4):253-9. doi: 10.1053/j.spid.2004.07.006. Semin Pediatr Infect Dis. 2004. PMID: 15494949 Review.

2

The epidemiologic and clinical importance of norovirus infection.

Atmar RL, Estes MK. Atmar RL, et al. Gastroenterol Clin North Am. 2006 Jun;35(2):275-90, viii. doi: 10.1016/j.gtc.2006.03.001. Gastroenterol Clin North Am. 2006. PMID: 16880066 Review.

3

Pandemic H5N1 influenza vaccine development: an update.

El Sahly HM, Keitel WA. El Sahly HM, et al. Expert Rev Vaccines. 2008 Mar;7(2):241-7. doi: 10.1586/14760584.7.2.241. Expert Rev Vaccines. 2008. PMID: 18324892 Review.

4

Preparing for a possible pandemic: influenza A/H5N1 vaccine development.

Keitel WA, Atmar RL. Keitel WA, et al. Curr Opin Pharmacol. 2007 Oct;7(5):484-90. doi: 10.1016/j.coph.2007.06.004. Epub 2007 Jul 17. Curr Opin Pharmacol. 2007. PMID: 17644429 Review.

5

A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea.

DuPont HL, Jiang ZD, Okhuysen PC, Ericsson CD, de la Cabada FJ, Ke S, DuPont MW, Martinez-Sandoval F. DuPont HL, et al. Ann Intern Med. 2005 May 17;142(10):805-12. doi: 10.7326/0003-4819-142-10-200505170-00005. Ann Intern Med. 2005. PMID: 15897530 Clinical Trial.

6

Norwalk virus shedding after experimental human infection.

Atmar RL, Opekun AR, Gilger MA, Estes MK, Crawford SE, Neill FH, Graham DY. Atmar RL, et al. Emerg Infect Dis. 2008 Oct;14(10):1553-7. doi: 10.3201/eid1410.080117. Emerg Infect Dis. 2008. PMID: 18826818 Free PMC article.

7

Safety, reactogenicity and immunogenicity of Francisella tularensis live vaccine strain in humans.

El Sahly HM, Atmar RL, Patel SM, Wells JM, Cate T, Ho M, Guo K, Pasetti MF, Lewis DE, Sztein MB, Keitel WA. El Sahly HM, et al. Vaccine. 2009 Aug 6;27(36):4905-11. doi: 10.1016/j.vaccine.2009.06.036. Epub 2009 Jun 28. Vaccine. 2009. PMID: 19567246 Free PMC article. Clinical Trial.

8

Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons.

Keitel WA, Atmar RL, Cate TR, Petersen NJ, Greenberg SB, Ruben F, Couch RB. Keitel WA, et al. Arch Intern Med. 2006 May 22;166(10):1121-7. doi: 10.1001/archinte.166.10.1121. Arch Intern Med. 2006. PMID: 16717175 Clinical Trial.

9

Enteroaggregative Escherichia coli: an emerging pathogen in children.

Huang DB, Dupont HL. Huang DB, et al. Semin Pediatr Infect Dis. 2004 Oct;15(4):266-71. doi: 10.1053/j.spid.2004.07.008. Semin Pediatr Infect Dis. 2004. PMID: 15494951

10

Genetic susceptibility to enteroaggregative Escherichia coli diarrhea: polymorphism in the interleukin-8 promotor region.

Jiang ZD, Okhuysen PC, Guo DC, He R, King TM, DuPont HL, Milewicz DM. Jiang ZD, et al. J Infect Dis. 2003 Aug 15;188(4):506-11. doi: 10.1086/377102. Epub 2003 Jul 25. J Infect Dis. 2003. PMID: 12898436

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Results by year